SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-028893
Filing Date
2023-08-10
Accepted
2023-08-10 16:30:15
Documents
47
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20230630.htm   iXBRL 10-Q 898640
2 EX-10.1 exhibit101rafconsultingagr.htm EX-10.1 76756
3 EX-10.2 exhibit102cdsconsultingagr.htm EX-10.2 76190
4 EX-31.1 a2023q2exhibit311.htm EX-31.1 11702
5 EX-32.1 a2023q2exhibit321.htm EX-32.1 5458
  Complete submission text file 0001628280-23-028893.txt   4037919

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20230630.xsd EX-101.SCH 30868
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20230630_cal.xml EX-101.CAL 31890
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20230630_def.xml EX-101.DEF 133471
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20230630_lab.xml EX-101.LAB 354462
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20230630_pre.xml EX-101.PRE 227775
41 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20230630_htm.xml XML 372475
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 231160014
SIC: 2834 Pharmaceutical Preparations